Related references
Note: Only part of the references are listed.A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
Alessandro Mantovani et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis
Yesmi A. Ortega Rojas et al.
ANNALS OF HEPATOLOGY (2022)
Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis
Kaneez Fatima et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Non-alcoholic Fatty Liver Disease in Sub-Saharan Africa 1 Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa
C. Wendy Spearman et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Health Care Costs of Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease Are Nearly Twice Those of Matched Controls
Hannes Hagstrom et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
Juan Pablo Arab et al.
ANNALS OF HEPATOLOGY (2020)
The Identification of Diabetes Mellitus Subtypes Applying Cluster Analysis Techniques: A Systematic Review
Antonio Sarria-Santamera et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
Pegah Golabi et al.
HEPATOLOGY COMMUNICATIONS (2020)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials
Iram Amanullah et al.
POSTGRADUATE MEDICAL JOURNAL (2019)
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
Maria Corina Plaz Torres et al.
NUTRIENTS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
Simona Leoni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Obesity and nonalcoholic fatty liver disease: current perspectives
Raiya Sarwar et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2018)
Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis
Toufik Mahfood Haddad et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
DIABETOLOGIA (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease
Zobair M. Younossi et al.
PHARMACOECONOMICS (2015)
Share Paper
